M. Bulman

757 total citations
16 papers, 560 citations indexed

About

M. Bulman is a scholar working on Genetics, Surgery and Molecular Biology. According to data from OpenAlex, M. Bulman has authored 16 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 7 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in M. Bulman's work include BRCA gene mutations in cancer (7 papers), Pancreatic function and diabetes (6 papers) and Diabetes and associated disorders (5 papers). M. Bulman is often cited by papers focused on BRCA gene mutations in cancer (7 papers), Pancreatic function and diabetes (6 papers) and Diabetes and associated disorders (5 papers). M. Bulman collaborates with scholars based in United Kingdom, United States and Mexico. M. Bulman's co-authors include Andrew T. Hattersley, Sian Ellard, Timothy M. Frayling, Lisa I.S. Allen, D. Gareth Evans, Maggie Shepherd, Fiona Lalloo, Julie Evans, Ewan R. Pearson and Michael Hannemann and has published in prestigious journals such as Diabetes, Diabetologia and Annals of Oncology.

In The Last Decade

M. Bulman

16 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Bulman United Kingdom 12 387 317 246 132 59 16 560
Antti Kyrönlahti Finland 16 206 0.5× 111 0.4× 333 1.4× 39 0.3× 77 1.3× 27 612
C. Diatloff‐Zito France 10 107 0.3× 126 0.4× 241 1.0× 87 0.7× 79 1.3× 20 387
José María Cantú Mexico 10 129 0.3× 56 0.2× 199 0.8× 87 0.7× 18 0.3× 17 377
Greg Landes United States 9 188 0.5× 61 0.2× 258 1.0× 241 1.8× 142 2.4× 9 726
Stacey C. Chapman United States 10 73 0.2× 132 0.4× 406 1.7× 92 0.7× 26 0.4× 10 500
Andrej Poleev Germany 7 86 0.2× 52 0.2× 347 1.4× 84 0.6× 31 0.5× 12 409
M. A. Timmerman Netherlands 14 119 0.3× 116 0.4× 426 1.7× 191 1.4× 50 0.8× 21 646
Marta Ciaccio Argentina 11 224 0.6× 53 0.2× 249 1.0× 190 1.4× 23 0.4× 33 509
Hiroko Misawa Japan 12 74 0.2× 53 0.2× 235 1.0× 154 1.2× 47 0.8× 17 450

Countries citing papers authored by M. Bulman

Since Specialization
Citations

This map shows the geographic impact of M. Bulman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Bulman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Bulman more than expected).

Fields of papers citing papers by M. Bulman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Bulman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Bulman. The network helps show where M. Bulman may publish in the future.

Co-authorship network of co-authors of M. Bulman

This figure shows the co-authorship network connecting the top 25 collaborators of M. Bulman. A scholar is included among the top collaborators of M. Bulman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Bulman. M. Bulman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Kontopoulos, Eftichia V., M. Bulman, Marí­a José Rodrí­guez, et al.. (2023). Clinical assessment of the fetal right Quantitative Lung Index. The Journal of Maternal-Fetal & Neonatal Medicine. 36(2). 2242555–2242555. 1 indexed citations
2.
Morgan, Robert D., M. Bulman, Andrew R. Clamp, et al.. (2019). Incidence of tumour BRCA1/2 variants in relapsed, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer. Annals of Oncology. 30. v413–v413. 1 indexed citations
3.
Smith, Miriam J., et al.. (2018). Sarcoma in neurofibromatosis 2: case report and review of the literature. Familial Cancer. 18(1). 97–100. 1 indexed citations
4.
Basu, Naren, James Hodson, Fiona Lalloo, et al.. (2015). Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis. Familial Cancer. 14(4). 531–538. 36 indexed citations
5.
Evans, D. Gareth, et al.. (2008). Probability of BRCA1/2 mutation varies with ovarian histology: results from screening 442 ovarian cancer families. Clinical Genetics. 73(4). 338–345. 25 indexed citations
6.
Boyd, Marie, M. Bulman, A Shenton, et al.. (2007). Response to correspondence on “Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening”. Journal of Medical Genetics. 44(8). e88–e88. 4 indexed citations
7.
Smith, Adrian L., Anthony Moran, Marie Boyd, et al.. (2006). Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening. Journal of Medical Genetics. 44(1). 10–15. 82 indexed citations
8.
Evans, D. Gareth, et al.. (2003). Sensitivity of BRCA1/2 mutation testing in 466 breast/ovarian cancer families. Journal of Medical Genetics. 40(9). e107–e107. 11 indexed citations
9.
Bulman, M., Lorna W. Harries, Torben Hansen, et al.. (2002). Abnormal splicing of hepatocyte nuclear factor 1 alpha in maturity-onset diabetes of the young. Diabetologia. 45(10). 1463–1467. 21 indexed citations
10.
Bulman, M., Ira Lemm, Jörn Lausen, et al.. (2002). Evidence for Haploinsufficiency of the Human HNF1α Gene Revealed by Functional Characterization of MODY3-Associated Mutations. Biological Chemistry. 383(11). 1691–700. 26 indexed citations
11.
Frayling, Timothy M., Julie Evans, M. Bulman, et al.. (2001). beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors.. Diabetes. 50(suppl_1). S94–S94. 202 indexed citations
12.
Evans, D. Gareth, et al.. (2001). High detection rate for BRCA2 mutations in male breast cancer families from North West England. Familial Cancer. 1(3-4). 131–133. 13 indexed citations
13.
14.
Frayling, Timothy M., M. Bulman, Yukio Horikawa, et al.. (1998). Mutations in hepatocyte nuclear factor 1beta are not a common cause of maturity-onset diabetes of the young in the U.K.. Diabetes. 47(7). 1152–1154. 40 indexed citations
15.
Bulman, M., M. J. Dronsfield, Timothy M. Frayling, et al.. (1997). A missense mutation in the hepatocyte nuclear factor 4 alpha gene in a UK pedigree with maturity-onset diabetes of the young. Diabetologia. 40(7). 859–862. 40 indexed citations
16.
Williams, Jim, M. Bulman, & Steven J. Neill. (1994). Wilt‐induced ABA biosynthesis, gene expression and down‐regulation of rbcS mRNA levels in Arabidopsis thaliana. Physiologia Plantarum. 91(2). 177–182. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antti Kyrönlahti Breakdown of academic impact, for papers by C. Diatloff‐Zito Breakdown of academic impact, for papers by José María Cantú Breakdown of academic impact, for papers by Greg Landes Breakdown of academic impact, for papers by Stacey C. Chapman Breakdown of academic impact, for papers by Andrej Poleev Breakdown of academic impact, for papers by M. A. Timmerman Breakdown of academic impact, for papers by Marta Ciaccio Breakdown of academic impact, for papers by Hiroko Misawa
Rankless by CCL
2026